Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Erlotinib 183321-74-6

Erlotinib 183321-74-6

Inquiry
  Post Date: May 07,2019
  Expiry Date: Nov 03,2019
  Detailed Description: Cas No. :183321-74-6 Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).

  CAS Registry Number:

183321-74-6
  Synonyms: ;4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline;n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine;4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-;ERLOTININ;Erlotinib & its intermediates (Developing);Erlotinib Base;
  Molecular Formula: C22H23N3O4
  Molecular Weight: 393.44
  Molecular Structure: 183321-74-6 Erlotinib

  Company: Shanghai Neopharm Co., Ltd.     [ China ]          
  Contact: Carol Zhu
  Tel: 021-58826758
  Fax: 021-58827258
  Email: sales@neopharm.com.cn
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.